SVE Capital
VC Fund
SVE Capital is an investment Firm.
- Total investments:
- 8
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries SVE Capital invests in
Stages SVE Capital invests in
Countries SVE Capital invests in
Investment Focus
Industry
- Biotechnology 4 (50%)
- Health Care 3 (38%)
- Therapeutics 3 (38%)
- Medical 2 (25%)
- Genetics 1 (13%)
Stage
- Seed 2 (25%)
- Series A 2 (25%)
- Series B 1 (13%)
- Series C 1 (13%)
- Funding Round 1 (13%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
SetPoint Medical
|
SetPoint Medical is a company that developed a device-based therapeutic approach for treating rheumatoid arthritis. The company's product, the SetPoint System, is a small, wireless implantable device that stimulates the vagus nerve to reduce inflammation. The therapy is an approach for adults with active rheumatoid arthritis who have notresponded to other treatments. | $80M / Jan 19, 2023 | |
|
SetPoint Medical
|
SetPoint Medical is a company that developed a device-based therapeutic approach for treating rheumatoid arthritis. The company's product, the SetPoint System, is a small, wireless implantable device that stimulates the vagus nerve to reduce inflammation. The therapy is an approach for adults with active rheumatoid arthritis who have notresponded to other treatments. | $80M / Series C / Jan 19, 2023 | |
Amplicore
|
Amplicore develops injectable and minimally invasive therapeutics for musculoskeletal disorders. | $4M / Seed / Mar 25, 2021 | |
|
SetPoint Medical
|
SetPoint Medical is a company that developed a device-based therapeutic approach for treating rheumatoid arthritis. The company's product, the SetPoint System, is a small, wireless implantable device that stimulates the vagus nerve to reduce inflammation. The therapy is an approach for adults with active rheumatoid arthritis who have notresponded to other treatments. | $64M / Jan 27, 2021 | |
|
SetPoint Medical
|
SetPoint Medical is a company that developed a device-based therapeutic approach for treating rheumatoid arthritis. The company's product, the SetPoint System, is a small, wireless implantable device that stimulates the vagus nerve to reduce inflammation. The therapy is an approach for adults with active rheumatoid arthritis who have notresponded to other treatments. | $64M / Series B / Jan 27, 2021 | |
SwineTech
|
SwineTech is a mechanical and industrial engineering company that bridges the gap between producers and pigs through artificial intelligence and sensor-based technologies. The company specializes in the fields of machine learning, audio, and pork production. SwineTech was founded in 2015 and headquartered in Cedar Rapids, Iowa. | $5M / Series A / Mar 13, 2020 | |
Valitor
|
Valitor, Inc. has developed novel methods of modifying therapeutic proteins to achieve substantial control over their pharmacokinetics, target specificity and bioactivity. Their technology platform can be broadly applied to improve the pharmacological properties of many protein drugs that are currently approved or under development. They currentlyhave three development pipelines in the fields of dermatology, ophthalmology, and orthopedics that highlight the capabilities of their novel drug products. | $2.5M / Series A / Sep 20, 2018 | |
DNALite Therapeutics
|
DNALite Therapeutics, Inc. is an early-stage preclinical biotechnology company committed on bringing the next-generation of drugs to the gastrointestinal tract. Currently for some gastrointestinal diseases, such as colorectal cancer and Crohn's disease, complete or partial removal of the colon and/or rectum is the only treatment Our aimis to prevent not manage the progression of theses diseases. We are doing this by harnessing our proprietary technology to carry DNA to cells that drive these diseases. | $1.5M / Seed / Aug 08, 2018 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does SVE Capital invest in?
SVE Capital invests primarily in Biotechnology, Health Care and Therapeutics startups, most often at Seed and Series A stage. Most of the 8 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did SVE Capital last invest?
The most recent investment recorded for SVE Capital closed in Jan 2023. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
